| Drug policy and the public good T Babor Oxford University Press, USA, 2010 | 621 | 2010 |
| Optimal control of nonlinear processes D Grass, JP Caulkins, G Feichtinger, G Tragler, DA Behrens Berlino: Springer, 2008 | 574 | 2008 |
| Marijuana legalization: What everyone needs to know® JP Caulkins, B Kilmer, MAR Kleiman Oxford University Press, 2016 | 430 | 2016 |
| Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state R Smart, JP Caulkins, B Kilmer, S Davenport, G Midgette Addiction 112 (12), 2167-2177, 2017 | 396 | 2017 |
| What price data tell us about drug markets JP Caulkins, P Reuter Journal of drug issues 28 (3), 593-612, 1998 | 383 | 1998 |
| Drug policy and the public good: evidence for effective interventions J Strang, T Babor, J Caulkins, B Fischer, D Foxcroft, K Humphreys The Lancet 379 (9810), 71-83, 2012 | 362 | 2012 |
| Public health implications of legalising the production and sale of cannabis for medicinal and recreational use W Hall, D Stjepanović, J Caulkins, M Lynskey, J Leung, G Campbell, ... The Lancet 394 (10208), 1580-1590, 2019 | 353 | 2019 |
| Developing public health regulations for marijuana: lessons from alcohol and tobacco RL Pacula, B Kilmer, AC Wagenaar, FJ Chaloupka, JP Caulkins American journal of public health 104 (6), 1021-1028, 2014 | 315 | 2014 |
| Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission K Humphreys, CL Shover, CM Andrews, ASB Bohnert, ML Brandeau, ... The Lancet 399 (10324), 555-604, 2022 | 303 | 2022 |
| Mandatory minimum drug sentences: throwing away the key or the taxpayers' money? JP Caulkins, CP Rydell, WL Schwabe, J Chiesa RAND-PUBLICATIONS-MR-ALL SERIES-, 1997 | 253 | 1997 |
| Considering marijuana legalization: Insights for Vermont and other jurisdictions JP Caulkins, B Kilmer, M Kleiman, RJ MacCoun, G Midgette, P Oglesby, ... Rand Corporation, 2015 | 240* | 2015 |
| How drug enforcement affects drug prices JP Caulkins, P Reuter Crime and Justice 39 (1), 213-271, 2010 | 209 | 2010 |
| Altered state?: assessing how marijuana legalization in California could influence marijuana consumption and public budgets B Kilmer, JP Caulkins, RL Pacula, RJ MacCoun, P Reuter RAND, 2010 | 209 | 2010 |
| Marijuana markets: Inferences from reports by the household population JP Caulkins, RL Pacula Journal of Drug Issues 36 (1), 173-200, 2006 | 201 | 2006 |
| Three strikes and you’re out: Estimated benefits and costs of California’s new mandatory-sentencing law PW Greenwood, K Model, JP Caulkins, SP Klein, A Abrahamse, J Chiesa, ... Rand Corporation, 1994 | 183 | 1994 |
| Drugs and drug policy: What everyone needs to know® MAR Kleiman, JP Caulkins, A Hawken Oxford University Press, 2011 | 178 | 2011 |
| Research note—Sell first, fix later: Impact of patching on software quality A Arora, JP Caulkins, R Telang Management Science 52 (3), 465-471, 2006 | 176 | 2006 |
| Price and purity analysis for illicit drug: Data and conceptual issues JP Caulkins Drug and alcohol dependence 90, S61-S68, 2007 | 169 | 2007 |
| Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine CP Rydell, JP Caulkins, SS Everingham Operations Research 44 (5), 687-695, 1996 | 167 | 1996 |
| A dynamic model of drug initiation: implications for treatment and drug control DA Behrens, JP Caulkins, G Tragler, JL Haunschmied, G Feichtinger Mathematical Biosciences 159 (1), 1-20, 1999 | 155 | 1999 |
